RL-007
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for RL-007, covering 2022-04-27 to 2025-07-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate RL-007 in the Treatment of Cognitive Impairment Associated With Schizophrenia (CIAS) [Phase 2]